Adenomyosis is a severe disease condition, wherein the normal tissue (endometrial tissue) surrounding the uterus enlarges and grows into the wall of the uterus which is more muscular in structure. These tissues continue to thicken, break down, and bleed during each menstrual cycle. This leads to an enlargement of the uterus with heavy bleeding and pain. The cause of adenomyosis is not definite, but the condition is neutralized after the menopause. The hormonal treatments or removal of the uterus, known as hysterectomy, cures adenomyosis. Common symptoms of adenomyosis include dysmenorrhea, menorrhagia, and pelvic pain. These do not appear in other conditions such as endometriosis, dysfunctional uterine bleeding, and leiomyoma. Imaging can be used for diagnosis and to plan better treatment. Accurate diagnosis can be only possible with the help of imaging. Hysterectomy is a definitive therapy for adenomyosis. Myometrium penetration is detected using imaging to analyze its extent and depth. Detecting the depth of the myometrium penetration is important to determine the level of treatment. Superficial adenomyosis also responds to receptors similar to deep adenomyosis. These conditions are monitored by observing the imaging procedures and examining the presence of any growth. The cell nests have high luteinizing hormone receptors. A number of these cells are without progesterone receptors. Hence, nest cells do not react to exogenous or endogenous progesterone, whereas pregnancy stops the progress of external endometriosis. The possibility of pregnancy leading to the invagination of basal endometrium and producing endometrial nests in the myometrium is taken into consideration. Adenomyosis could occur due to the direct intrusion of endometrial cells in the uterus to the muscle which forms the walls of uterine. Uterine intrusion is made when a cesarean section operation is conducted. This could enhance the direct incision of the endometrial cells into the uterus walls. Adenomyosis could also develop within the muscle of the uterine from endometrial tissue accumulated there at the time when the uterus first evolved in the fetus. Other cause of the condition is inflammation due to childbirth. Inflammation caused in the uterine and its lining in the course of postpartum period can lead to a disruption in the normal borders of cells which line up the uterus. Other surgical procedures related to or on the uterus will yield the same effect. The rarest cause of adenomyosis is bone marrow stem cells invading the muscles of the uterine.
Increase in incidence of adenomyosis is a major driver of the global adenomyosis treatment market. Rise in funds from the government for R&D, increase in knowledge about the condition, advanced medical technology, new drugs, treatment, and therapies are the other factors propelling the global market.
The global adenomyosis treatment market can be segmented based on type, diagnosis, treatment, and region. In terms of type, the market can be categorized into adenomyoma, focal, diffuse, and others. Based on diagnosis, the global adenomyosis treatment market can be classified into magnetic resonance imaging (MRI), endometrial biopsy, and ultrasound. In terms of treatment, the market can be divided into anti-inflammatory drugs, hormone medications, hysterectomy, and others. Hysterectomy is the primary and most popular procedure for the treatment of adenomyosis.
In terms of region, the global adenomyosis treatment market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is projected to be a major market for adenomyosis treatment during the forecast period.
Key players operating in the global adenomyosis treatment market are Bayer AG, Johnson & Johnson Consumer, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Ferring B.V., and Specialty European Pharma, among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.